Heim-Kreisig Symptom

Gaima-Kraiziha synoma is not a classic symptom of myocardial infarction, but serves as one of the signs of an erased form of unstable angina pectoris resulting from progressive atherosclerotic lesions of the coronary arteries.

GCS occurs in approximately 20% of all patients with nonspecific signs of coronary artery disease and in all patients with bright PVCs with syncope, high (more than 70 mm Hg) blood pressure, antianginal therapy with drugs from the nitrate group. Often diagnostics are carried out in parallel or even during periods

The Gaima-Kreisig symptom is a clinical sign that is used in medicine to diagnose and monitor patients with chronic pulmonary diseases such as bronchial asthma, chronic obstructive pulmonary disease and others.

Heim-Keysig syndrome is named after two physicians, E. L. Heim, who first described it in 1947, and Friedrich Ludwig Kreysig, who refined its definition and clinical significance in 1886. Cough plays a key role in the symptom. According to the length of the day, it can be: night type (frequency most often occurs within a period of 2-3 hours until night); morning type (that is, appears mainly in the middle of the day or closer to the morning); daytime type (cough occurs only in the morning, after which it is practically absent until the next night).

To diagnose the Haym-Keisig symptom, factors such as: participation of the respiratory department in the cough are taken into account; changes in the nature of breathing: breathing turns into an expiratory pattern - with a decrease in the rate of exhalation and some lag in inspiration, although respiratory movements occur frequently (with shortness of breath); reduction in forced expiratory volume to 75% of the expected value when conducting a test with a bronchodilator; identifying a patient’s morning cough - often with clear sputum; the level of carbon monoxide in the blood of a patient without inhalers should not exceed 38 µmol/l and increases when taking a bronchodilator.

Let's summarize: Gayma-crentia syndrome is an important prognostic parameter that allows you to assess the course of the disease and prescribe appropriate therapy. Diagnosis of Gayma-kresig-sipdrome includes anamnesis analysis, assessment of external respiratory function and the use of special tests. Treatment of maxillary sinus syndrome is based on the use of drugs to expand the bronchial lumen, as well as improving the general condition of the patient.